Saeed Kalantari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saeed Kalantari has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Abtin Ebadi Amooghin
Department of Chemical Engineering, Faculty of Engineering, Arak University, Arak 38156-8-8349, Iran
1 shared publication - Amirhossein Aliakbar
Department of Biostatistics, Faculty of Public Health, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Azadeh Laali
Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Erfaneh Movahedi
Department of Internal Medicine, School of Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Fahimeh Safarnezhad Tameshkel
Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Farhad Zamani
Department of Physics Institute for Advanced Studies in Basic Sciences 45195-1159 Zanjan Iran
1 shared publication
Latest Publications
- Open Access
- 10 September 2021
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
Evaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir); a randomized clinical trial
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection and treatment are significant health organizations’ concerns worldwide. Although there is no proven drug license against the virus, a variety of components have under investigation. Objectives: In this regard, the present study was intended to evaluate the consequences of Sovodak (sofosbuvir/ daclatasvir) treatment in COVID-19 patients compared with Kaletra (lopinavir/ritonavir). Patients and Methods: This study was conducted as a randomized trial using 120 COVID19 confirmed cases between August 19th and September 19th, 2020, in which subjects were classified into two treatment groups, 58 (Sovodak group) and 54 (Kaletra group). Related statistical operations calculated significant outcomes such as survival rate and hazard ratio by SPSS version 16. Sovodak was composed of sofosbuvir 400mg and daclatasvir 60mg, and Kaletra included lopinavir 400 mg and ritonavir 100 mg. Results: We observed that there was no significant difference concerning the comorbidities, death, intensive care unit admission, remission. Besides, Kaletra had a higher rate of discharge versus Sovodak [HR=1.551 (95% CI=1.008-2.386), P =0.046] and a better outcome was observed in patients receiving. Conclusion: Sovodak compared to Kaletra by Hazard plot. Sovodak (sofosbuvir/daclatasvir) therapy in COVID19 cases was accompanied by a significantly higher survival rate and better outcome than Kaletra (lopinavir/ritonavir). Trial Registration: This study has been registered in the Iranian Registry of Clinical Trials (identifier: IRCT20200328046885N1; https://en.irct.ir/trial/47565, Ethical code #IR.IUMS.FMD.REC.1399.407).
- 10 September 2021
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
Open AccessEvaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir); a randomized clinical trial
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection and treatment are significant health organizations’ concerns worldwide. Although there is no proven drug license against the virus, a variety of components have under investigation. Objectives: In this regard, the present study was intended to evaluate the consequences of Sovodak (sofosbuvir/ daclatasvir) treatment in COVID-19 patients compared with Kaletra (lopinavir/ritonavir). Patients and Methods: This study was conducted as a randomized trial using 120 COVID19 confirmed cases between August 19th and September 19th, 2020, in which subjects were classified into two treatment groups, 58 (Sovodak group) and 54 (Kaletra group). Related statistical operations calculated significant outcomes such as survival rate and hazard ratio by SPSS version 16. Sovodak was composed of sofosbuvir 400mg and daclatasvir 60mg, and Kaletra included lopinavir 400 mg and ritonavir 100 mg. Results: We observed that there was no significant difference concerning the comorbidities, death, intensive care unit admission, remission. Besides, Kaletra had a higher rate of discharge versus Sovodak [HR=1.551 (95% CI=1.008-2.386), P =0.046] and a better outcome was observed in patients receiving. Conclusion: Sovodak compared to Kaletra by Hazard plot. Sovodak (sofosbuvir/daclatasvir) therapy in COVID19 cases was accompanied by a significantly higher survival rate and better outcome than Kaletra (lopinavir/ritonavir). Trial Registration: This study has been registered in the Iranian Registry of Clinical Trials (identifier: IRCT20200328046885N1; https://en.irct.ir/trial/47565, Ethical code #IR.IUMS.FMD.REC.1399.407).
- 26 November 2019
- Published by Elsevier in Applied Materials Today
- Vol. 18, 100491
Superior interfacial design in ternary mixed matrix membranes to enhance the CO2 separation performance
- 26 November 2019
- Published by Elsevier in Applied Materials Today
- Vol. 18, 100491
Superior interfacial design in ternary mixed matrix membranes to enhance the CO2 separation performance
- 1 January 2018
- Published by GN1 Sistemas e Publicacoes Ltd. in The International Tinnitus Journal
- Vol. 22 (1) , 35-39
The Diagnostic Value of Color Doppler Ultrasonography in Predicting Thyroid Nodules Malignancy
Background and Objective: Thyroid nodules are common medical and surgical problems. Although ultrasound has been proposed for evaluation of these nodules by many studies, but there is no consensus regarding its diagnostic accuracy and discriminatory cutoffs. We aimed to investigate the diagnostic value of Gray-scale and Color Doppler US in predicting thyroid nodules malignancy. Method: This is an analytical cross-sectional study which was conducted on 63 patients with thyroid nodules. The patients with nodular goiter were evaluated by Color Doppler and Gray scale US, fine needle aspiration and surgery was performed in all the subjects. The sensitivity, specificity, positive predictive value, and negative predictive value of the finding in US and their cut offs were calculated. Data were analyzed by Chi-square and Mann Whitney U test in SPSS19. P-value less than 0.05 considered as statistically significant. Results: 63 patients consisting of 55 (87.3%) female and 8 (12.7%) male patients with the age range of 20-70 years were enrolled in this study. 14% of nodules were reported as malignant in pathology. Singularity, hypo echogenicity, irregular margin, and micro calcification were significantly correlated with malignancy in nodules (p<0.05). Micro calcification and hypo echogenicity of the nodule were the most and the least discriminator of malignancy in nodules (sensitivity 77%, specificity 76% vs. 24%, PPV 41% vs. , 14% and NPV 94% vs. 86%) respectively. Pulsatility Index and Mean Systolic Velocity were the most and the least predictor factors of thyroid malignancy (PPV 62% vs. 23% and NPV 100% vs. 91%, respectively). There was a significant association between Resistive Index and Pulsatility Index with malignancy with a cutoff of RI ≥ 0.715 (P=0.005) and PI ≥ 0.945 (P=0.007), respectively. The combination of calcification, RI ≥ 0.715 with PI ≥ 0.945 had a very diagnostic yield for diagnose of malignancy (PPV 66.6% and NPV 98.4%). Conclusion: According to results, it seems that Grayscale US combined with Color Doppler are valuable modalities for evaluating thyroid nodules and can be used as a para-clinical method in order to assess the risk of malignancy in the patient with thyroid nodules.
- 1 January 2018
- Published by GN1 Sistemas e Publicacoes Ltd. in The International Tinnitus Journal
- Vol. 22 (1) , 35-39
The Diagnostic Value of Color Doppler Ultrasonography in Predicting Thyroid Nodules Malignancy
Background and Objective: Thyroid nodules are common medical and surgical problems. Although ultrasound has been proposed for evaluation of these nodules by many studies, but there is no consensus regarding its diagnostic accuracy and discriminatory cutoffs. We aimed to investigate the diagnostic value of Gray-scale and Color Doppler US in predicting thyroid nodules malignancy. Method: This is an analytical cross-sectional study which was conducted on 63 patients with thyroid nodules. The patients with nodular goiter were evaluated by Color Doppler and Gray scale US, fine needle aspiration and surgery was performed in all the subjects. The sensitivity, specificity, positive predictive value, and negative predictive value of the finding in US and their cut offs were calculated. Data were analyzed by Chi-square and Mann Whitney U test in SPSS19. P-value less than 0.05 considered as statistically significant. Results: 63 patients consisting of 55 (87.3%) female and 8 (12.7%) male patients with the age range of 20-70 years were enrolled in this study. 14% of nodules were reported as malignant in pathology. Singularity, hypo echogenicity, irregular margin, and micro calcification were significantly correlated with malignancy in nodules (p<0.05). Micro calcification and hypo echogenicity of the nodule were the most and the least discriminator of malignancy in nodules (sensitivity 77%, specificity 76% vs. 24%, PPV 41% vs. , 14% and NPV 94% vs. 86%) respectively. Pulsatility Index and Mean Systolic Velocity were the most and the least predictor factors of thyroid malignancy (PPV 62% vs. 23% and NPV 100% vs. 91%, respectively). There was a significant association between Resistive Index and Pulsatility Index with malignancy with a cutoff of RI ≥ 0.715 (P=0.005) and PI ≥ 0.945 (P=0.007), respectively. The combination of calcification, RI ≥ 0.715 with PI ≥ 0.945 had a very diagnostic yield for diagnose of malignancy (PPV 66.6% and NPV 98.4%). Conclusion: According to results, it seems that Grayscale US combined with Color Doppler are valuable modalities for evaluating thyroid nodules and can be used as a para-clinical method in order to assess the risk of malignancy in the patient with thyroid nodules.
- Open Access
- 1 January 2015
- Published by Medknow in Journal of Research in Medical Sciences
- Vol. 20 (11) , 1070-6
Thyroid gland volume off schoolchildren in the North of Iran: Comparison with other studies
Background: Few studies have shown the limitation of the World Health Organization (WHO)/ International Council for the Control of Iodine Deficiency (ICCIDD)-adopted thyroid gland volume references as universal normative values for thyroid gland volume. So we decided to measure thyroid gland volume by sonography in schoolchildren in Rasht, Gilan Province, Iran - Rasht is a metropolitan city on the Caspian Sea coast - and compare them to WHO normative values. Materials and Methods: In a cross-sectional study, 2,522 schoolchildren, aged 6-13 years, in Rasht, Gilan Province, Iran were selected by multistage random sampling. Data were collected on their age, sex, weight, height, body surface area (BSA), and thyroid gland size by palpation and sonography. The terminal phalange of thumb finger volume was calculated with the same formula used in sonography, for the thyroid gland in 1,085 of these cases. Results: Goiter prevalence was 64% (1613 cases) by palpation, 76.1% (1228 subjects) grade I and 23.9% (385 cases) grade II. The mean thyroid gland volume in girls was more than boys (3.67 ± 1.89 mL vs 3.41 ± 1.58 mL, P < 0.0001). According to the 1997 WHO thyroid gland volume reference, none of the children had goiter based on BSA and age even in those with grade II goiters (23.9%). In contrast, the median thyroid gland volume in our cases was larger than the 2004 WHO reference. The best single predictor of thyroid gland volume was age (R2 = 0.391, P < 0.0001) followed by BSA (R2 = 0.151, P < 0.0001). There was also a significant difference between thyroid gland and finger volume in all grades of goiter and grade II goiters (3 ± 1.4 mL vs 9.59 ± 2.4 mL; P < 0.0001. 4.3 ± 1.4 mL vs 9.3 ± 2.5 mL; P < 0.0001). Conclusion: The WHO standards for thyroid gland volume by sonography may underestimate or overestimate the goiter prevalence in many areas and populations. Finger volume was much larger than thyroid gland volume in even visible goiters.
- 1 January 2015
- Published by Medknow in Journal of Research in Medical Sciences
- Vol. 20 (11) , 1070-6
Open AccessThyroid gland volume off schoolchildren in the North of Iran: Comparison with other studies
Background: Few studies have shown the limitation of the World Health Organization (WHO)/ International Council for the Control of Iodine Deficiency (ICCIDD)-adopted thyroid gland volume references as universal normative values for thyroid gland volume. So we decided to measure thyroid gland volume by sonography in schoolchildren in Rasht, Gilan Province, Iran - Rasht is a metropolitan city on the Caspian Sea coast - and compare them to WHO normative values. Materials and Methods: In a cross-sectional study, 2,522 schoolchildren, aged 6-13 years, in Rasht, Gilan Province, Iran were selected by multistage random sampling. Data were collected on their age, sex, weight, height, body surface area (BSA), and thyroid gland size by palpation and sonography. The terminal phalange of thumb finger volume was calculated with the same formula used in sonography, for the thyroid gland in 1,085 of these cases. Results: Goiter prevalence was 64% (1613 cases) by palpation, 76.1% (1228 subjects) grade I and 23.9% (385 cases) grade II. The mean thyroid gland volume in girls was more than boys (3.67 ± 1.89 mL vs 3.41 ± 1.58 mL, P < 0.0001). According to the 1997 WHO thyroid gland volume reference, none of the children had goiter based on BSA and age even in those with grade II goiters (23.9%). In contrast, the median thyroid gland volume in our cases was larger than the 2004 WHO reference. The best single predictor of thyroid gland volume was age (R2 = 0.391, P < 0.0001) followed by BSA (R2 = 0.151, P < 0.0001). There was also a significant difference between thyroid gland and finger volume in all grades of goiter and grade II goiters (3 ± 1.4 mL vs 9.59 ± 2.4 mL; P < 0.0001. 4.3 ± 1.4 mL vs 9.3 ± 2.5 mL; P < 0.0001). Conclusion: The WHO standards for thyroid gland volume by sonography may underestimate or overestimate the goiter prevalence in many areas and populations. Finger volume was much larger than thyroid gland volume in even visible goiters.